A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AADACL2 | Arylacetamide deacetylase-like 2 | Predicted secreted proteins
| | | | | Tissue enriched |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABHD1 | Abhydrolase domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD15 | Abhydrolase domain containing 15 | Predicted secreted proteins
| | | | | Mixed |
ABI3BP | ABI family, member 3 (NESH) binding protein | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AC002451.1 | Protein LOC100996577 | Predicted secreted proteins
| | | | | Not detected |
AC006116.20 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enriched |
AC006126.3 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC016586.1 | | Predicted secreted proteins
| | | | | Not detected |
AC022532.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC027307.3 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC061992.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC079354.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Mixed |
AC092964.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC105020.1 | Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 | | | | | | Tissue enhanced |
AC114783.1 | Protein LOC339760 | Predicted secreted proteins
| | | | | Tissue enriched |
AC132192.1 | LOC644656 protein; Uncharacterized protein | Predicted secreted proteins
| | | | | Mixed |
AC138393.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC144568.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACAN | Aggrecan | Predicted secreted proteins
| | | | | Mixed |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE | Angiotensin-converting enzyme; Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACP2 | Acid phosphatase 2, lysosomal | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ACPL2 | Acid phosphatase-like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ACTL10 | Actin-like 10 | Predicted secreted proteins
| | | | | Tissue enriched |
ACTR3C | ARP3 actin-related protein 3 homolog C (yeast) | | | | | | Mixed |
ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ACYP1 | Acylphosphatase 1, erythrocyte (common) type | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM15 | ADAM metallopeptidase domain 15 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM18 | ADAM metallopeptidase domain 18 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |